Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 43.73B | 50.20B | 45.52B | 37.55B | 30.37B |
Gross Profit | 12.53B | 15.53B | 14.37B | 11.93B | 8.49B |
EBITDA | 5.04B | 7.97B | 7.15B | 5.71B | 3.38B |
Net Income | 2.02B | 4.56B | 4.03B | 2.89B | 1.46B |
Balance Sheet | |||||
Total Assets | 66.80B | 60.16B | 55.10B | 47.51B | 35.05B |
Cash, Cash Equivalents and Short-Term Investments | 16.40B | 11.89B | 12.65B | 12.33B | 4.92B |
Total Debt | 11.82B | 9.36B | 6.38B | 5.48B | 10.25B |
Total Liabilities | 26.24B | 30.19B | 30.24B | 27.18B | 19.97B |
Stockholders Equity | 40.56B | 29.98B | 24.86B | 20.33B | 15.08B |
Cash Flow | |||||
Free Cash Flow | -5.92B | -2.09B | -486.00M | 10.50B | 5.07B |
Operating Cash Flow | -2.11B | 929.00M | 2.68B | 11.67B | 5.92B |
Investing Cash Flow | -5.09B | -3.63B | -3.08B | -1.55B | -919.00M |
Financing Cash Flow | 10.49B | 1.24B | 406.00M | -3.15B | -3.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
86 Outperform | ¥30.78B | 8.02 | 3.18% | 7.43% | 18.47% | ||
80 Outperform | ¥28.80B | 12.26 | 4.40% | 4.40% | 18.82% | ||
73 Outperform | ¥5.69B | 13.16 | 3.86% | 0.20% | -40.35% | ||
71 Outperform | ¥32.48B | 14.88 | 3.29% | -12.88% | -70.22% | ||
69 Neutral | ¥11.62B | 20.23 | 2.54% | -10.39% | -43.57% | ||
65 Neutral | $11.18B | 15.79 | 5.49% | 1.92% | 3.14% | -24.90% | |
63 Neutral | ¥8.91B | 16.61 | 0.59% | 27.24% | -53.52% |